CD44 and cancer: To investigate the specific binding affinity of CD44-mediated endocytosis, three different cell types were selected for cytotoxicity analysis: one normal fibroblast (low expression) and two different cancer cells, including triple-negative breast cancer (MDA-MB-231, CD44 positive) and liver cancer cells (HepG2, CD44 negative).